FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $161,000 | -27.5% | 26,357 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $222,000 | -2.6% | 26,983 | +5.8% | 0.00% | 0.0% |
| Q1 2021 | $228,000 | -22.4% | 25,515 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $294,000 | +7.7% | 25,447 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $273,000 | -0.7% | 26,178 | +25.0% | 0.00% | 0.0% |
| Q2 2020 | $275,000 | +75.2% | 20,942 | +4.7% | 0.00% | 0.0% |
| Q1 2020 | $157,000 | -64.2% | 19,995 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $438,000 | +50.0% | 21,150 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $292,000 | +10.6% | 21,329 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $264,000 | -1.1% | 21,477 | +0.3% | 0.00% | 0.0% |
| Q1 2019 | $267,000 | +6.8% | 21,419 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $250,000 | -40.0% | 22,113 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $417,000 | -26.3% | 22,283 | +1.8% | 0.00% | -50.0% |
| Q2 2018 | $566,000 | +20.7% | 21,882 | +4.5% | 0.00% | 0.0% |
| Q1 2018 | $469,000 | -15.2% | 20,949 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $553,000 | +23.2% | 22,076 | +18.8% | 0.00% | 0.0% |
| Q3 2017 | $449,000 | +29.0% | 18,585 | +8.1% | 0.00% | +100.0% |
| Q2 2017 | $348,000 | -20.2% | 17,196 | +6.1% | 0.00% | -50.0% |
| Q1 2017 | $436,000 | +115.8% | 16,212 | +52.3% | 0.00% | +100.0% |
| Q4 2016 | $202,000 | -99.9% | 10,643 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $208,531,000 | +30.8% | 10,672 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $159,467,000 | +75.2% | 10,656 | +8.2% | 0.00% | – |
| Q1 2016 | $91,000,000 | -52.1% | 9,846 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $190,000,000 | +130037.0% | 9,846 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $146,000 | -99.9% | 9,861 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $215,660,000 | +89.3% | 9,852 | +94.7% | 0.00% | – |
| Q1 2015 | $113,951,000 | -11.3% | 5,060 | -20.4% | 0.00% | -100.0% |
| Q4 2014 | $128,408,000 | +103.6% | 6,360 | +84.1% | 0.00% | – |
| Q3 2014 | $63,071,000 | +22.2% | 3,454 | -9.8% | 0.00% | – |
| Q2 2014 | $51,628,000 | – | 3,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|